Medical errors are still harming patients. AI could help change that.
'During situations such as trauma, or a patient doing poorly, there's a real rush to try and get emergency drugs into the patient as fast as possible,' said Wiederspan, a nurse anesthetist at UW Medicine in Seattle. 'And that's when mistakes can occur, when you're flustered, your adrenaline's rushing, you're drawing up drugs and you're trying to push them.'
Despite ongoing efforts to improve patient safety, it's estimated that at least 1 in 20 patients still experience medical mistakes in the health care system. One of the most common categories of mistakes is medication errors, where for one reason or another, a patient is given either the wrong dose of a drug or the wrong drug altogether. In the U.S., these errors injure approximately 1.3 million people a year and result in one death each day, according to the World Health Organization.
In response, many hospitals have introduced guardrails, ranging from color coding schemes that make it easier to differentiate between similarly named drugs, to barcode scanners that verify that the correct medicine has been given to the correct patient.
Despite these attempts, medication mistakes still occur with alarming regularity.
'I had read some studies that said basically 90% of anesthesiologists admit to having a medication error at some point in their career,' said Dr. Kelly Michaelsen, Wiederspan's colleague at UW Medicine and an assistant professor of anesthesiology and pain medicine at the University of Washington. She started to wonder whether emerging technologies could help.
As both a medical professional and a trained engineer, it struck her that spotting an error about to be made, and alerting the anesthesiologists in real time, should be within the capabilities of AI. 'I was like, 'This seems like something that shouldn't be too hard for AI to do,'' she said. 'Ninety-nine percent of the medications we use are these same 10-20 drugs, and so my idea was that we could train an AI to recognize them and act as a second set of eyes.'
Michaelsen focused on vial swap errors, which account for around 20% of all medication mistakes.
All injectable drugs come in labeled vials, which are then transferred to a labeled syringe on a medication cart in the operating room. But in some cases, someone selects the wrong vial, or the syringe is labeled incorrectly, and the patient is injected with the wrong drug.
In one particularly notorious vial swap error, a 75-year-old woman being treated at Vanderbilt University Medical Center in Tennessee was injected with a fatal dose of the paralyzing drug vecuronium instead of the sedative Versed, resulting in her death and a subsequent high-profile criminal trial.
Michaelsen thought such tragedies could be prevented through 'smart eyewear' — adding an AI-powered wearable camera to the protective eyeglasses worn by all staff during operations. Working with her colleagues in the University of Washington computer science department, she designed a system that can scan the immediate environment for syringe and vial labels, read them and detect whether they match up.
'It zooms in on the label and detects, say, propofol inside the syringe, but ondansetron inside the vial, and so it produces a warning,' she said. 'Or the two labels are the same, so that's all good, move on with your day.'
Building the device took Michaelsen and her team more than three years, half of which was spent getting approval to use prerecorded video streams of anesthesiologists correctly preparing medications inside the operating room. Once given the green light, she was able to train the AI on this data, along with additional footage — this time in a lab setting — of mistakes being made.
'There's lots of issues with alarm fatigue in the operating room, so we had to make sure it works very well, it can do a near perfect job of detecting errors, and so [if used for real] it wouldn't be giving false alarms,' she said. 'For obvious ethical reasons, we couldn't be making mistakes on purpose with patients involved, so we did that in a simulated operating room.'
In a study published late last year, Michaelsen reported that the device detected vial swap errors with 99.6% accuracy. All that's left is to decide the best way for warning messages to be relayed and it could be ready for real-world use, pending Food and Drug Administration clearance. The study was not funded by AI tech companies.
'I'm leaning towards auditory feedback because a lot of the headsets like GoPro or Google Glasses have built-in microphones,' she said. 'Just a little warning message which makes sure people stop for a second and make sure they're doing what they think they're doing.'
Wiederspan has tested the device and said he's optimistic about its potential for improving patient safety, although he described the current GoPro headset as being a little bulky.
'Once it gets a bit smaller, I think you're going to get more buy-in from anesthesia providers to use it,' Wiederspan said. 'But I think it's going to be great. Anything that's going to make our job a little bit easier, spot any potential mistakes and help bring our focus back to the patient is a good thing.'
Patient safety advocates have been calling for the implementation of error-preventing AI tools for some time. Dr. Dan Cole, vice chair of the anesthesiology department at UCLA Health and president of the Anesthesia Patient Safety Foundation, likened their potential for reducing risk to that of self-driving cars and improving road safety.
But while Cole is encouraged by the UW study and other AI-based research projects to prevent prescribing and dispensing errors in pharmacies, he said there are still questions surrounding the most effective ways to integrate these technologies into clinical care.
'The UW trial idea was indeed a breakthrough,' he said. 'As with driverless taxis, I'm a bit reluctant to use the technology at this point, but based on the potential for improved safety, I am quite sure I will use it in the future.'
Melissa Sheldrick, a patient safety advocate from Ontario who lost her 8-year-old son Andrew to a medication error in 2016, echoed those thoughts.
Sheldrick said that while technology can make a difference, the root cause of many medical errors is often a series of contributing factors, from lack of communication to vital data being compartmentalized within separate hospital departments or systems.
'Technology is an important layer in safety, but it's just one layer and cannot be relied upon as a fail-safe,' she said.
Others feel that AI can play a key role in preventing mistakes, particularly in demanding environments such as the operating room and emergency room, where creating more checklists and asking for extra vigilance has proved ineffective at stopping errors.
'These interventions either add friction or demand perfect attention from already overburdened providers in a sometimes chaotic reality with numerous distractions and competing priorities,' said Dr. Nicholas Cordella, an assistant professor of medicine at Boston University's Chobanian & Avedisian School of Medicine. 'AI-enabled cameras allow for passive monitoring without adding cognitive burden to clinicians and staff.'
AI tools are likely to be deployed to prevent errors in an even broader range of situations. At UW Medicine, Michaelsen is considering expanding her device to also detect the volume of the drug present in a syringe, as a way of preventing underdosing and overdosing errors.
'This is another area where harm can occur, especially in pediatrics, because you've got patients [in the same department] where there can be a hundredfold difference in size, from a brand-new premature baby to an overweight 18-year-old,' she said. 'Sometimes we have to dilute medications, but as you do dilutions there's chances for errors. It isn't happening to every single patient, but we do this enough times a day and to enough people that there is a possibility for people to get injured.'
Wiederspan said he can also see AI-powered wearable cameras being used in the emergency room and on the hospital floor to help prevent errors when dispensing oral medications.
'I know Kelly's currently working on using the system with intravenous drugs, but if it can be tailored to oral medications, I think that's going to help too,' Wiederspan said. 'I used to work in a cardiac unit, and sometimes these patients are on a plethora of drugs, a little cup full of all these pills. So maybe the AI can catch errors there as well.'
Of course, broader uses of AI throughout a hospital also come with data protection and privacy concerns, especially if the technology happens to be scanning patient faces and screens or documents containing their medical information. In UW Medicine's case, Michaelsen said this is not an issue as the tool is only trained to look for labels on syringes, and does not actively store any data.
'Privacy concerns represent a significant challenge with passive, always-on camera technology,' Cordella said. 'There needs to be clear standards with monitoring for breaches, and the technology should be introduced with full transparency to both patients and health care staff.'
He also noted the possibility of more insidious issues such as clinicians starting to excessively rely on AI, reducing their own vigilance and neglecting traditional safety practices.
'There's also a potential slippery slope here,' Cordella said. 'If this technology proves successful for medication error detection, there could be pressure to expand it to monitor other aspects of clinician behavior, raising ethical questions about the boundary between a supportive safety tool and intrusive workplace monitoring.'
But while the prospect of AI entering hospitals on a wider basis certainly presents the need for stringent oversight, many who work in the operating room feel it has enormous potential to do good by keeping patients safe and buying medical professionals valuable time in critical situations.
'Time is of the essence in an emergency situation where you're trying to give blood, lifesaving medications, checking vital signs, and you're trying to rush through these processes,' Wiederspan said. 'I think that's where this kind of wearable technology can really come into play, helping us shave off vital seconds and create more time where we can really focus on the patient.'
This article was originally published on NBCNews.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Jefferies Reaffirms ‘Buy' Rating on LivaNova PLC (LIVN) with $79 PT
Offering strong upside potential, LivaNova PLC (NASDAQ:LIVN) earns a spot on our list of the . A closeup shot of a laboratory technician handling a medical device used for fertility treatments. On June 5, 2025, LivaNova PLC (NASDAQ:LIVN) reported the completion of its landmark CORE-VNS study. More than 800 real-world patients with drug-resistant epilepsy were tracked under this study. The results were positive. Significant and lasting seizure reductions were noted, confirming VNS Therapy's effectiveness in both children and adults. In some cases, a 100% reduction was noted. In response to the positive results, Jefferies reaffirmed its 'Buy' rating the following day, with a $79 price target. The analyst attributed it to strong product cycles, including upgrades to the company's Essenz platform and growing oxygenator market share. Previously, in May, Wolfe Research also upgraded the stock to 'Outperform', highlighting the improved legal clarity in Italy and high growth potential in its depression and sleep apnea treatment pipelines. Through its Cardiopulmonary and Neuromodulation segments, LivaNova PLC (NASDAQ:LIVN) develops products and therapies for neurological and cardiac patients worldwide. It remains on our list of the most undervalued stocks. While we acknowledge the potential of LIVN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Most Undervalued Cloud Stocks Under $10 According to Hedge Funds and 11 Best Mineral Stocks to Buy According to Hedge Funds. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
15 minutes ago
- Yahoo
Value-Based Care Leader, Equality Health, Launches Rebrand with Simple, Bold Commitment: "Dedicated to Better"
PHOENIX, July 30, 2025 /PRNewswire/ -- Equality Health, a leading innovator in value-based care delivery for diverse and underserved communities, today unveiled a comprehensive brand refresh underscored by a powerful new tagline: Dedicated to Better. This rebrand marks a renewed commitment to transforming healthcare for those who need it most by simplifying the complex and fragmented system that challenges providers and payers, but more importantly, patients. The refreshed brand embodies Equality Health's mission to transform health outcomes, streamline value-based care (VBC) operations and elevate the experiences for stakeholders. Built specifically for Medicaid populations and under-resourced communities that have long been underserved, Equality Health's unique and proven care model is at the heart of this renewed identity. "We all agree that today's healthcare system isn't working for everyone — especially those facing economic, cultural, or systemic barriers to care," said Michael Poku, M.D., MBA, FACP, Chief Medical Officer at Equality Health. "We must do better! Our new branding is more than an outward message to the marketplace, it embodies our core DNA and the daily, intense focus of all Equality Health associates in our unwavering commitment to partner with payers, providers, patients, local resources and communities to make healthcare work better for all." A Medicaid-First Approach to Value-Based CareEquality Health's unique approach is rooted in its Medicaid expertise, having more attributed Medicaid members than any other VBC enabler in the U.S. The company provides wrap-around support, hyper-local resourcing, and augmented operational capabilities to empower providers — especially independent practices — to succeed in value-based payment models. Through culturally sensitive care strategies and a proprietary technology platform, CareEmpower, which leverages electronic health record (EHR) and healthcare information exchange (HIE) data along with predictive modeling and care-tracking tools, Equality Health enables smarter, more personalized patient engagement resulting in better health outcomes. Community-Centered, Outcome-FocusedThe new brand expression, Dedicated to Better, highlights Equality Health's commitment not only to simplifying care for providers and health plans but to improving the lives of people within the communities they serve. This includes a continued focus on the social determinants of health (SDoH), with programs designed to meet patients where they are, both geographically and culturally. Additionally, through the Equality Health Foundation, the organization invests directly into local neighborhoods, supporting initiatives covering education, access to healthy food and ultimately expanding access to care to drive health equity. Adapting to Constant Change in Medicaid AdministrationEquality Health's Dedicated to Better ethos is even more important when addressing the future of the Medicaid program, which is about to change again. Analysts expect the newly enacted One Big Beautiful Bill Act (OBBBA) to have measurable impacts on Medicaid populations in most states over the next decade. The OBBBA could saddle states with tighter funding and heavier verification rules for Medicaid participation, especially with work-requirement checks. Confronting these challenges head-on is precisely why Equality Health remains Medicaid-first—equipping providers with real-time data, SDoH resources, and streamlined value-based workflows that protect coverage, keep high-risk members connected to care, and sustain practice revenue even as federal funding support shrinks. Dedicated to Better means equipping providers with the data and tools they need to directly address changes and support patients regardless of administrative changes. Continued Medicaid Innovation: AIEquality Health is partnering with UnityAI, a healthcare technology company that uses voice AI agents to make member outreach more personal, scalable, and effective. The partnership is launching with a focus on well-child visits, helping Medicaid families schedule the preventive care their children need to stay healthy. UnityAI engages members on Equality Health's behalf through warm, conversational phone calls in multiple languages that guide families through scheduling, answer common questions, and connect them directly to a care specialist when needed. These voice-powered interactions integrate seamlessly into CareEmpower, giving Equality Health's care teams better tools to reach more families with less friction. This collaboration advances the Dedicated to Better promise by making healthcare more approachable, more accessible, and more responsive to the needs of the communities Equality Health serves. Equality Health anticipates announcing new partnerships with nonprofits and other organizations to further advance innovation within its care model. A Successful Model Delivering ResultsKey benefits of Equality Health's focus include: Expert VBC Enablement: Grounded in Medicaid, designed for scale Inclusive Provider Support: Especially for independent primary care practices Meaningful Engagement: Cross-cultural outreach and patient activation Operational Excellence: Improving profitability, resource efficiency, and shared risk Technology-Driven Insights: Predictive analytics that enhance care tracking and coordination "Being Dedicated to Better means showing up every day to improve the patient experience, support providers with the right tools and insights, and collaborate with payers to transform communities," said Justin Contre, marketing leader with Equality Health. "It's not just a tagline — it's our north star." To learn more about Equality Health's rebrand and its impact, click here. About Equality Health Equality Health is a technology-enabled primary care platform that leverages the proven capabilities of value-based payment models to transform healthcare for diverse and often marginalized populations. From predictive modeling to advanced care-tracking tools, utilizing Equality Health's proprietary software, participating PCPs can streamline value-based administration and stay one step ahead of a patient's journey. Equality Health's care model is Medicaid-first in design and includes more than 25 health plans, over 4,100 PCPs and 825,000 lives across Arizona, Texas, Tennessee, Louisiana and Virginia. Equality Health partners with practices to close care gaps, optimize performance, increase compliance, and improve profitability. Members engage with holistic and personalized programs delivered through the lens of social and cultural needs. Equality Health is revolutionizing how care is delivered through hyper-local resources at scale and establishing critical linkages with payers, providers, members, and community resources. For more information about Equality Health, visit or follow EqualityHealth on Facebook, @EqualityHealth on Twitter, and EqualityHealth on LinkedIn. Media Contact:Mardi Larson, Amendola for Equality Health, mlarson@ View original content to download multimedia: SOURCE Equality Health Sign in to access your portfolio
Yahoo
15 minutes ago
- Yahoo
Lively's 2025 HSA Spend Report Highlighting How Americans Are Navigating Skyrocketing Healthcare Costs
Behind the Spend: What the latest HSA Data Tells Us About Healthcare, Inflation, and Consumer Stress SAN FRANCISCO, July 30, 2025--(BUSINESS WIRE)--Lively, Inc., a top-rated health and lifestyle benefits platform* known for building the modern Health Savings Account (HSA), today unveiled its latest and the 7th annual 2025 HSA Spend Report, revealing how U.S. account holders are using their HSAs to cope with record-high healthcare prices—and what it means for employers, brokers, and benefits teams. "Amidst rising prescription costs and economic uncertainty, our account holders are proving that HSAs are more than a short‑term fix—they're building longer‑term health and wealth stability," said Shobin Uralil, Co‑founder & COO of Lively. "Our 2025 Spend Report highlights how informed benefits strategies—backed by an intuitive platform—can shift HSAs from healthcare wallets to wealth-building assets." Key Report Insights Withdrawals rose 13% in 2024, from $1,162 to $1,320, closely mirroring the national average of $1,370. Hospital spending increased 5%, underscoring how HSAs are helping consumers manage rising care costs in real time. The percentage of assets retained dropped to 20%, signaling that consumers are increasingly tapping into their healthcare savings. Why it matters now: As inflation unnerves consumers and medical costs keep climbing, HSAs are proving to be more than just expense accounts—they're becoming essential financial safety nets. Lively's data demonstrates that with the right provider, employees don't just spend—they actively save, invest, and build wealth for the future. Read the full report: About Lively Lively is the health and lifestyle benefits provider that gets it right. Our solutions are designed to take the guesswork out of managing benefits and drive efficiency for HR teams. Our innovative platform combines robust features with unparalleled service, to make maximizing your benefits as simple as it should be. Lively currently offers HSA, FSA, HRA, COBRA, Direct Bill, Commuter, Lifestyle Spending Accounts, and Medical Travel *Lively's HSA is top-rated according to Morningstar's 2024 Health Savings Account Landscape, G2, Trustpilot, and Lively's Customer Satisfaction survey. View source version on Contacts press@